SCHEMBL13612925

SCHEMBL13612925

Cc1ccc(S(=O)(=O)OC[C@@H]2C[C@@H](O[Si](C)(C)C(C)(C)C)CN2)cc1

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 6/20 0.32
NOS1 P29475 6/20 0.32
NOS2 P35228 6/20 0.32
CYP3A4 P08684 3/20 0.32
CYP2C19 P33261 2/20 0.32
CYP2D6 P10635 4/20 0.32
ALDH1A1 P00352 4/20 0.31
TSHR P16473 2/20 0.31
CYP2C9 P11712 1/20 0.31
MAPT P10636 1/20 0.31
MAPK1 P28482 1/20 0.31
STAT3 P40763 1/20 0.31
KDM4E B2RXH2 1/20 0.31
CA12 O43570 1/20 0.30
CA1 P00915 1/20 0.30
CA9 Q16790 1/20 0.30
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30
G6PD P11413 1/20 0.30
CYP1A2 P05177 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27228919 0.82 ALDH1A1 (0.36) CYP3A4CYP2C19CYP2D6ALDH1A1TSHR
SCHEMBL3386471 0.82 ALDH1A1 (0.36) CYP3A4CYP2C19CYP2D6ALDH1A1TSHR
SCHEMBL3386468 0.82 ALDH1A1 (0.36) CYP3A4CYP2C19CYP2D6ALDH1A1TSHR
SCHEMBL21760775 0.79 CYP2D6 (0.36) CYP3A4CYP2C19CYP2D6ALDH1A1TSHR
SCHEMBL1133701 0.79 CYP2D6 (0.36) CYP3A4CYP2C19CYP2D6ALDH1A1TSHR
SCHEMBL1845464 0.79 CYP2D6 (0.36) CYP3A4CYP2C19CYP2D6ALDH1A1TSHR
SCHEMBL14901300 0.79 CA12 (0.34) CYP3A4CYP2C19CYP2D6ALDH1A1TSHR
SCHEMBL2065728 0.78 ALDH1A1 (0.37) CYP3A4CYP2C19CYP2D6ALDH1A1TSHR
SCHEMBL10024024 0.78 ALDH1A1 (0.37) CYP3A4CYP2C19CYP2D6ALDH1A1TSHR
SCHEMBL9283567 0.78 ALDH1A1 (0.37) CYP3A4CYP2C19CYP2D6ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090286792-A1 3-CYCLOALKYLAMINOPYRROLIDINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTORS XUE CHU-BIAO 2009-11-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286792-A1 3-CYCLOALKYLAMINOPYRROLIDINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTORS CCR2, CCR5, CXCR3 NOS3 952/4885NOS1 1563/4885NOS2 2013/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.